Iovance Biotherapeutics, Inc. (IOVA) vs Ligand Pharmaceuticals Incorporated (LGND)

• Iovance Biotherapeutics, Inc. IOVA 13.58 ▼ −7.74%
• Ligand Pharmaceuticals Incorporated LGND 295.54 ▼ −0.99%

Iovance Biotherapeutics, Inc. and Ligand Pharmaceuticals Incorporated are both Biotechnology companies. Iovance Biotherapeutics, Inc. is the larger, with a market value of $6.7B against $6.0B — 1.1× the size. Iovance Biotherapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 29.5×. Ligand Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 54.9% against 34.6%. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs −89.1%) and the higher return on invested capital (8.19% vs −43.0%). Across the 17 metrics below, Ligand Pharmaceuticals Incorporated leads on 14 and Iovance Biotherapeutics, Inc. on 3.